miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 8, Issue 10, Pages e3103
Publisher
Springer Nature
Online
2017-10-12
DOI
10.1038/cddis.2017.499
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-455 inhibits breast cancer cell proliferation through targeting CDK14
- (2017) Bing Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer
- (2017) Dejun Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- miR-34a is downregulated in human osteosarcoma stem-like cells and promotes invasion, tumorigenic ability and self-renewal capacity
- (2017) Yonggen Zou et al. Molecular Medicine Reports
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Germline and somatic genetics of osteosarcoma — connecting aetiology, biology and therapy
- (2017) D. Matthew Gianferante et al. Nature Reviews Endocrinology
- MicroRNA-21 Inhibits the Apoptosis of Osteosarcoma Cell Line SAOS-2 via Targeting Caspase 8
- (2017) Bin Xu et al. ONCOLOGY RESEARCH
- Re-calculating! Navigating through the osteosarcoma treatment roadblock
- (2017) J. McGuire et al. PHARMACOLOGICAL RESEARCH
- A meta-analysis of randomized control trials of surgical methods with osteosarcoma outcomes
- (2017) Xiaojun He et al. Journal of Orthopaedic Surgery and Research
- MicroRNA-143 promotes apoptosis of osteosarcoma cells by caspase-3 activation via targeting Bcl-2
- (2016) Wei-hua Li et al. BIOMEDICINE & PHARMACOTHERAPY
- miR-21 predicts poor prognosis in patients with osteosarcoma
- (2016) Xianfeng Ren et al. BRITISH JOURNAL OF BIOMEDICAL SCIENCE
- Cyclin-dependent kinase pathways as targets for womenʼs cancer treatment
- (2016) Gottfried E. Konecny CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Future directions in the treatment of osteosarcoma
- (2016) Michael W. Bishop et al. CURRENT OPINION IN PEDIATRICS
- The role of pharmacogenetics in the treatment of osteosarcoma
- (2016) Hanneke I. Vos et al. DRUG DISCOVERY TODAY
- Cyclin-Dependent Kinase 14 Promotes Cell Proliferation, Migration and Invasion in Ovarian Cancer by Inhibiting Wnt Signaling Pathway
- (2016) Jun Ou-Yang et al. GYNECOLOGIC AND OBSTETRIC INVESTIGATION
- Activation/Proliferation-associated Protein 2 (Caprin-2) Positively Regulates CDK14/Cyclin Y-mediated Lipoprotein Receptor-related Protein 5 and 6 (LRP5/6) Constitutive Phosphorylation
- (2016) Xin Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The IL-1β/AP-1/miR-30a/ADAMTS-5 axis regulates cartilage matrix degradation in human osteoarthritis
- (2016) Quanbo Ji et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- miR-105/Runx2 axis mediates FGF2-induced ADAMTS expression in osteoarthritis cartilage
- (2016) Quanbo Ji et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- MicroRNAs in Cardiovascular Disease
- (2016) Temo Barwari et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Treating cancer with selective CDK4/6 inhibitors
- (2016) Ben O'Leary et al. Nature Reviews Clinical Oncology
- A network-biology perspective of microRNA function and dysfunction in cancer
- (2016) Cameron P. Bracken et al. NATURE REVIEWS GENETICS
- Knockdown of PFTAIRE Protein Kinase 1 (PFTK1) Inhibits Proliferation, Invasion, and EMT in Colon Cancer Cells
- (2016) Jiankang Zhu et al. ONCOLOGY RESEARCH
- Knockdown of PFTK1 Expression by RNAi Inhibits the Proliferation and Invasion of Human Non-Small Lung Adenocarcinoma Cells
- (2016) Mei-han Liu et al. ONCOLOGY RESEARCH
- Applied Nanotechnology and Nanoscience in Orthopedic Oncology
- (2016) Olga D. Savvidou et al. ORTHOPEDICS
- Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer: Past, Present, and Future
- (2016) Adam J. DiPippo et al. PHARMACOTHERAPY
- Cyclin-Dependent Kinases as Coregulators of Inflammatory Gene Expression
- (2016) M. Lienhard Schmitz et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Pharmacological cyclin dependent kinase inhibitors: Implications for colorectal cancer
- (2016) Archana Balakrishnan et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Long noncoding RNAs in the progression, metastasis and prognosis of osteosarcoma
- (2016) Zuozhang Yang et al. Cell Death & Disease
- MicroRNAs in vascular tissue engineering and post-ischemic neovascularization
- (2015) Massimo Caputo et al. ADVANCED DRUG DELIVERY REVIEWS
- MicroRNAs in liver tissue engineering — New promises for failing organs
- (2015) Nathanael Raschzok et al. ADVANCED DRUG DELIVERY REVIEWS
- An overview of microRNAs
- (2015) Scott M. Hammond ADVANCED DRUG DELIVERY REVIEWS
- Cyclin-Dependent Kinase Inhibitors and the Treatment of Gastrointestinal Cancers
- (2015) Sameh Mikhail et al. AMERICAN JOURNAL OF PATHOLOGY
- Molecular Pathways: Targeting the Cyclin D-CDK4/6 Axis for Cancer Treatment
- (2015) T. VanArsdale et al. CLINICAL CANCER RESEARCH
- miR-216a may inhibit pancreatic tumor growth by targeting JAK2
- (2015) Bao-hua Hou et al. FEBS LETTERS
- Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
- (2015) Michael S. Isakoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Signaling by exosomal microRNAs in cancer
- (2015) Germana Falcone et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Upregulated PFTK1 promotes tumor cell proliferation, migration, and invasion in breast cancer
- (2015) Xiaoling Gu et al. MEDICAL ONCOLOGY
- MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B
- (2015) LEI LI et al. Molecular Medicine Reports
- miR-382 Inhibits Osteosarcoma Metastasis and Relapse by Targeting Y Box-Binding Protein 1
- (2015) Meng Xu et al. MOLECULAR THERAPY
- The history and future of targeting cyclin-dependent kinases in cancer therapy
- (2015) Uzma Asghar et al. NATURE REVIEWS DRUG DISCOVERY
- Co-targeting BRAF and cyclin dependent kinases 4/6 for BRAF mutant cancers
- (2015) Vipin Yadav et al. PHARMACOLOGY & THERAPEUTICS
- PFTK1 Promotes Gastric Cancer Progression by Regulating Proliferation, Migration and Invasion
- (2015) Lei Yang et al. PLoS One
- MicroRNA Library-Based Functional Screening Identified Androgen-Sensitive miR-216a as a Player in Bicalutamide Resistance in Prostate Cancer
- (2015) Toshiaki Miyazaki et al. Journal of Clinical Medicine
- miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma
- (2015) Meng Xu et al. Oncotarget
- MicroRNAome genome: A treasure for cancer diagnosis and therapy
- (2014) Ioana Berindan-Neagoe et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MicroRNAs: master regulators of drug resistance, stemness, and metastasis
- (2014) Umar Raza et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- The miRNA23b-regulated signaling network as a key to cancer development—implications for translational research and therapeutics
- (2014) Vignesh Viswanathan et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Cyclin-dependent kinases
- (2014) Marcos Malumbres GENOME BIOLOGY
- MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer
- (2013) Hongping Xia et al. HEPATOLOGY
- Targeting nuclear kinases in cancer: Development of cell cycle kinase inhibitors
- (2013) Todd M. Pitts et al. PHARMACOLOGY & THERAPEUTICS
- Overexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma
- (2012) H Miyagaki et al. BRITISH JOURNAL OF CANCER
- Androgen pathway stimulates MicroRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis
- (2012) Po-Jen Chen et al. HEPATOLOGY
- Senescence: a new weapon for cancer therapy
- (2012) Juan Carlos Acosta et al. TRENDS IN CELL BIOLOGY
- A novel interplay between oncogenic PFTK1 protein kinase and tumor suppressor TAGLN2 in the control of liver cancer cell motility
- (2011) W K C Leung et al. ONCOGENE
- MicroRNAs as Regulators of Differentiation and Cell Fate Decisions
- (2010) Kathryn N. Ivey et al. Cell Stem Cell
- Emerging links between CDK cell cycle regulators and Wnt signaling
- (2010) Gary Davidson et al. TRENDS IN CELL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started